401 related articles for article (PubMed ID: 25142830)
1. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
[TBL] [Abstract][Full Text] [Related]
4. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
5. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
6. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function.
Liu YH; Liu Y; Zhou YL; Yu DQ; He PC; Xie NJ; Li HL; Wei-Guo ; Chen JY; Tan N
Medicine (Baltimore); 2015 Apr; 94(13):e358. PubMed ID: 25837748
[TBL] [Abstract][Full Text] [Related]
7. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.
Jaubert MP; Armero S; Bonello L; Nicoud A; Sbragia P; Paganelli F; Arques S
Arch Cardiovasc Dis; 2010 Jan; 103(1):3-9. PubMed ID: 20142114
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study.
Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Luccioni R; Ambrosi P
Echocardiography; 2007 May; 24(5):499-507. PubMed ID: 17456069
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
[TBL] [Abstract][Full Text] [Related]
11. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide levels predict functional capacity in postcardiac surgery patients.
Salustri A; Cerquetani E; Piccoli M; Pastena G; Amici E; La Carrubba S; Bakir S; Al Mahmeed WA
J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):167-72. PubMed ID: 21178638
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
15. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
16. Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients.
Niizuma S; Iwanaga Y; Yahata T; Goto Y; Kita T; Miyazaki S; Nakahama H
Nephrol Dial Transplant; 2009 Feb; 24(2):597-603. PubMed ID: 18762474
[TBL] [Abstract][Full Text] [Related]
17. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.
Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C
Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983
[TBL] [Abstract][Full Text] [Related]
19. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]